New grant will further HIV/AIDS research in Zimbabwe
A UCSF Bixby Center program in Zimbabwe recently received a seven-year grant for $70 million to further its groundbreaking HIV/AIDS treatment and prevention research efforts. The University of Zimbabwe-University of California, San Francisco, Collaborative Research Program (UZ-UCSF) received this new funding through National Institutes of Health initiative that aims to improve collaboration and coordination of HIV/AIDS-related clinical trials.
UZ-UCSF, led by Dr. Zvavahera (Mike) Chirenje, was established in 1994 to implement high quality science addressing HIV prevention and treatment. Its areas of focus include:
- New treatment options for HIV-positive adults, including a cure.
- Diseases and conditions that occur frequently among HIV-positive people, such as tuberculosis and hepatitis.
- Improving the health of HIV-positive mothers and children.
- Microbicides to provide women with improved HIV prevention options.
During its 20 years of advancing HIV/AIDS science, UZ-UCSF has supported several noteworthy research efforts. For instance, the program has conducted many studies that have advanced the understanding of women's sexual health and HIV. Among its current research efforts, the program is investigating:
- Whether an antiretroviral drug can prevent HIV during breastfeeding in infants born to HIV-positive mothers.
- New microbicide options for women, including a gel and daily pills.
- Effective methods to empower HIV-positive adolescents to ensure their economic success, achieve better access to care, and improve their overall health.